Us Drug Market
- All
- News
- Videos
-
US Revives Drug Origin Debate, Cites Indian Exports
- Friday January 30, 2026
- World News | Indo-Asian News Service
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
- Friday October 10, 2025
- World News | Edited by NDTV News Desk
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
www.ndtv.com
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
Could Dogs Live Longer? Breakthrough Pill Receives Key Regulator Approval
- Monday March 24, 2025
- Feature | Edited by Abhinav Singh
FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.
-
www.ndtv.com
-
Cipla, Glenmark Recall Asthma Drugs Made In Indore From US Market
- Sunday May 5, 2024
- India News | Press Trust of India
Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator.
-
www.ndtv.com
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
- Wednesday November 29, 2023
- Science | Edited by Nikhil Pandey
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
www.ndtv.com
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
- Monday August 28, 2023
- India News | Press Trust of India
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
- Saturday February 18, 2023
- India News | Press Trust of India
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
- Saturday February 11, 2023
- India News | Press Trust of India
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
www.ndtv.com
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
- Monday August 29, 2022
- India News | Press Trust of India
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
www.ndtv.com
-
FDA Announces All Juul E-Cigarettes, Vaping Products Off Market Over Safety Concerns
- Friday June 24, 2022
- Agence France-Presse
The US Food and Drug Administration has ordered all vaping products produced by Juul Labs off the market after finding the former industry leader had failed to address certain safety concerns. Juul was blamed for a surge in youth vaping over its marketing of fruit and candy flavored e-cigarettes.
-
www.gadgets360.com
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
- Wednesday February 9, 2022
- India News | Press Trust of India
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
www.ndtv.com
-
US Revives Drug Origin Debate, Cites Indian Exports
- Friday January 30, 2026
- World News | Indo-Asian News Service
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
- Friday October 10, 2025
- World News | Edited by NDTV News Desk
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
www.ndtv.com
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
Could Dogs Live Longer? Breakthrough Pill Receives Key Regulator Approval
- Monday March 24, 2025
- Feature | Edited by Abhinav Singh
FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.
-
www.ndtv.com
-
Cipla, Glenmark Recall Asthma Drugs Made In Indore From US Market
- Sunday May 5, 2024
- India News | Press Trust of India
Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator.
-
www.ndtv.com
-
Miracle Drug That Could Extend Dogs' Lives Inches Closer to Approval
- Wednesday November 29, 2023
- Science | Edited by Nikhil Pandey
A medication with the potential to prolong the lifespans of large dogs and contribute to their overall health in aging is nearing its market debut.
-
www.ndtv.com
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
- Monday August 28, 2023
- India News | Press Trust of India
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
- Saturday February 18, 2023
- India News | Press Trust of India
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
- Saturday February 11, 2023
- India News | Press Trust of India
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
www.ndtv.com
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
- Monday August 29, 2022
- India News | Press Trust of India
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
www.ndtv.com
-
FDA Announces All Juul E-Cigarettes, Vaping Products Off Market Over Safety Concerns
- Friday June 24, 2022
- Agence France-Presse
The US Food and Drug Administration has ordered all vaping products produced by Juul Labs off the market after finding the former industry leader had failed to address certain safety concerns. Juul was blamed for a surge in youth vaping over its marketing of fruit and candy flavored e-cigarettes.
-
www.gadgets360.com
-
Dr Reddy's Laboratories Gets FDA Approval, Launches Drug In US Market
- Wednesday February 9, 2022
- India News | Press Trust of India
Dr Reddy's Laboratories on Wednesday said it has launched a vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.
-
www.ndtv.com